Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PS
3351
CALL
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $1.27M | ﹤0.01% |
+39,600
| New | +$1.16M |
|
3352
PUT
Ashland
ASH
$3.36B
| $1.27M | ﹤0.01% |
15,100
-7,700
| -34% | -$642K |
|
3353
iShares Currency Hedged MSCI Japan ETF
HEWJ
$769M
| $1.27M | ﹤0.01% |
36,966
+15,033
| +69% | +$487K |
|
3354
PUT
Heron Therapeutics
HRTX
$63.5M
| $1.27M | ﹤0.01% |
40,000
+25,000
| +167% | +$931K |
|
|
ESPR
3355
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.26M | ﹤0.01% |
28,500
+27,700
| +3,463% | +$1.27M |
|
|
SWN
3356
CALL
DELISTED
Southwestern Energy Company
SWN
| $1.26M | ﹤0.01% |
247,600
-15,400
| -6% | -$81.7K |
|
3357
CALL
iShares MSCI Turkey ETF
TUR
$220M
| $1.26M | ﹤0.01% |
53,100
+35,100
| +195% | +$852K |
|
|
ASNA
3358
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.26M | ﹤0.01% |
13,842
+2,744
| +25% | +$227K |
|
3359
Phibro Animal Health
PAHC
$1.37B
| $1.26M | ﹤0.01% |
29,439
+21,066
| +252% | +$995K |
|
|
BDXA
3360
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $1.26M | ﹤0.01% |
19,311
+18,265
| +1,746% | +$1.17M |
|
3361
Cerus
CERS
$572M
| $1.26M | ﹤0.01% |
174,765
-101,622
| -37% | -$738K |
|
3362
CALL
iShares MSCI Japan ETF
EWJ
$23.2B
| $1.26M | ﹤0.01% |
20,900
-130,100
| -86% | -$7.56M |
|
|
TGP
3363
DELISTED
Teekay LNG Partners L.P.
TGP
| $1.25M | ﹤0.01% |
75,128
+32,967
| +78% | +$527K |
|
3364
Pricesmart
PSMT
$5.49B
| $1.25M | ﹤0.01% |
15,488
+10,716
| +225% | +$897K |
|
3365
Sasol
SSL
$7.17B
| $1.25M | ﹤0.01% |
32,403
+8,464
| +35% | +$321K |
|
3366
Zillow
ZG
$8.15B
| $1.25M | ﹤0.01% |
28,357
+14,955
| +112% | +$782K |
|
3367
Ares Capital
ARCC
$14.5B
| $1.25M | ﹤0.01% |
72,815
-16,391
| -18% | -$281K |
|
3368
CALL
Progressive
PGR
$121B
| $1.25M | ﹤0.01% |
17,600
+4,000
| +29% | +$257K |
|
3369
CALL
Public Storage
PSA
$60.4B
| $1.25M | ﹤0.01% |
6,200
-41,600
| -87% | -$8.98M |
|
|
BRS
3370
DELISTED
Bristow Group, Inc.
BRS
| $1.25M | ﹤0.01% |
102,896
+42,342
| +70% | +$523K |
|
|
NSTG
3371
PUT
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.25M | ﹤0.01% |
+70,000
| New | +$1.02M |
|
3372
PUT
Diageo
DEO
$52.8B
| $1.25M | ﹤0.01% |
8,800
-4,000
| -31% | -$574K |
|
|
ALLK
3373
DELISTED
Allakos
ALLK
| $1.25M | ﹤0.01% |
+27,700
| New | +$1.14M |
|
3374
iShares Semiconductor ETF
SOXX
$46.6B
| $1.24M | ﹤0.01% |
20,163
+8,451
| +72% | +$522K |
|
3375
PUT
Toyota
TM
$223B
| $1.24M | ﹤0.01% |
10,000
+1,800
| +22% | +$228K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.